Jeffrey L. Benovic,Richard Carr, III,Douglas G. Tilley
申请号：
US15768428
公开号：
US20180353567A1
申请日:
2016.10.17
申请国别(地区):
US
年份:
2018
代理人:
摘要：
A pharmaceutical composition and methods of administering the same for treatment of cardiovascular disease comprising a pepducin having a sequence SEQ ID No. 1, wherein said composition stimulates cardiomyocyte contractility and activating the β2AR/β-arrestin signaling pathway.
